# Exploratory Study of NS-089/NCNP-02 in DMD

> **NCT04129294** · PHASE1,PHASE2 · COMPLETED · sponsor: **National Center of Neurology and Psychiatry, Japan** · enrollment: 6 (actual)

## Conditions studied

- Duchenne Muscular Dystrophy

## Interventions

- **DRUG:** NS-089/NCNP-02

## Key facts

- **NCT ID:** NCT04129294
- **Lead sponsor:** National Center of Neurology and Psychiatry, Japan
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-02
- **Primary completion:** 2022-05-31
- **Final completion:** 2022-05-31
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2022-09-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04129294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04129294, "Exploratory Study of NS-089/NCNP-02 in DMD". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04129294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*